The new regimen is for adults with unresectable or metastatic HER2-positive breast cancer that did not worsen during initial ...

The FDA’s October 2026 approval of pirtobrutinib gives adults with previously untreated CLL/SLL (without del17p) another ...

Cancer doesn’t discriminate — it affects people young and old, public and private. Award-winning adult film actress and model Marica Hase is one of many figures who has been going through a cancer ...

Sports broadcaster Julie Stewart-Binks, 39, was diagnosed with squamous cell carcinoma on her nose after mistaking it for a stubborn pimple and underwent Mohs surgery to remove the cancer. Mohs ...

First Annual Mammogram Caught Reporter's Early Stage Breast Cancer Jackie DeAngelis, a co-host of “The Big Money Show” on Fox Business was diagnosed with stage 1 breast cancer after her first annual ...

A wave of new FDA approvals is giving breast cancer patients across multiple subtypes — from triple‑negative to HR+/HER2‑ disease — more options and more hope this year. Dr. Sarah Premji says patients ...

The controversial radio host had rejected such traditional treatments as radiation and chemotherapy. About 174,650 men will be diagnosed with prostate cancer this year in the U.S., and about 31,620 ...

If you’re eligible for a stem cell transplant, the data is clear: patients who get one live longer than those who don’t. However, not everyone is eligible for a stem cell transplant because of the ...

MTV “The Challenge” and “Road Rules” star Ayanna Mackins, 45, is battling metastatic breast cancer. The mother of four underwent genetic testing to learn she’s a carrier of the BRCA gene mutation, ...

Many patients who have myelodysplastic syndrome (MDS), a type of blood cancer, will have to deal with some degree of anemia. Anemia occurs when a person does not have enough healthy red blood cells.

Rusfertide is a new FDA‑approved treatment that helps people with polycythemia vera keep their hematocrit below 45% and ...

Progress against B-ALL continues, including work from researchers at Amgen, who are focused on developing treatment ...